As of Mar 26
| +0.67 / +1.83%|
The 9 analysts offering 12-month price forecasts for Wuxi Pharmatech Cayman Inc have a median target of 39.50, with a high estimate of 47.00 and a low estimate of 30.00. The median estimate represents a +5.95% increase from the last price of 37.28.
The current consensus among 11 polled investment analysts is to Hold stock in Wuxi Pharmatech Cayman Inc. This rating has held steady since March, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.